ClinicalTrials.gg
Not yet recruitingNCT06970717Updated May 14, 2025

Programmable Smart Watch for Remote Pre-habilitation/Rehabilitation Monitoring

An interventional study of M5Stick Programmable watch in Rehabilitation Exercise, sponsored by Changi General Hospital. Not yet recruiting at 1 site in Singapore. Open to participants aged 21 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-14.

Sponsored by Changi General Hospital · Not applicable, Interventional, and Other

From the registry’s dates

  • Primary completion was expected by Feb 2026, 7 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
21 Years to 60 Years
Sex
All
01

Study summary

The purpose of this research study is to validate the M5Stick Programmable watch as a prototype to monitor specific prehabilitation exercises and to monitor the frequency of exercises and the number of repetitions the subject makes in a home setting.

Read the detailed description

Background of study Locally, a digital platform, the Cancer prehabilitation exercise diary was developed by Singhealth Marcom with Changi General Hospital (CGH) to support a home-based cancer prehabilitation program complete with exercise videos and reminders. The disadvantage of home-based or remote rehabilitation and prehabilitation compared to a centre-based treatment is that of a lack of monitoring and reduced compliance. In the CGH home-based model of cancer prehabilitation, compliance is monitored by verbal confirmation over a telephone call made by the cancer prehabilitation coordinator at mid-point of the course, and then with verbal checking with the patient at the end of the prehabilitation program, at the pre-op visit.

With the direction of increased digitalization for healthcare of the future, there is a desire to develop a smart watch that allows for the monitoring of the frequency and accuracy of the exercises prescribed asynchronously. A summary of the patient's exercise frequency/intensity and accuracy can be gathered from the app on the accompanying tablet.

This prototype will be developed through collaboration with the Eastern General Hospital {EGH) Engineering department. There is currently no product on the market that will be customizable for the specific calisthenic and plyometric exercises that are part of the cancer prehabilitation exercise videos.

Specific aims of this study This study aims to validate the MSStick Programmable watch as a prototype to monitor specific prehabilitation exercises and to monitor the frequency of exercises and the number of repetitions the subject makes in a home setting.

Hypothesis of this study The hypothesis is that the MSStick Programmable watch is able to monitor the specific prehabilitation exercises performed in a home-setting by healthy volunteers, and is able to distinguish its frequency and number of repetitions

Importance of this study This project aims to develop a programmable smartwatch for remote prehabilitation/rehabilitation monitoring. We address the limitations of current home-based programs by enabling asynchronous monitoring of exercise frequency, accuracy, and intensity. The smartwatch utilizes a 6-axis Inertial Measurement Unit (IMU) to differentiate specific exercises and measure workout intensity.

Prototype validation will involve 20 healthy volunteers performing 7 pre-defined exercises. The smartwatch will capture data and compare it with volunteer logs to assess Its ability to capture specific and accurate data.

Based on the findings, further refinement of the programming, prototype, and work processes may be necessary. Future steps include cloud-based data transmission, commercialization, and validation with specific patient populations. This smartwatch has the potential to be an important tool for scaling up telerehabilitation and teleprehabilitation programs.

02

Conditions studied

  • Rehabilitation Exercise
03

In context

Lead sponsor

Changi General Hospital is the lead sponsor of 101 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age 21-60
  2. Not on follow up for chronic diseases
  3. Willing to perform exercises daily x 5 days
  4. Able to handle simple technology eg. smart phone

Exclusion criteria

Exclusion Criteria:

  1. Pregnant women
  2. Active joint pains and any other musculoskeletal issues
  3. Heart conditions or balance issues
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Intervention arm

    Device: M5Stick Programmable watch

Interventions

  • DeviceM5Stick Programmable watch

    This smart watch is fashioned using a M5StickC, an IOT platform which is programmable and allows us to measure specific exercises.

06

What researchers measure

Primary outcomes

  1. Exercise Compliance

    Measure if the exercises were performed as prescribed, based on the number of repetitions, the number of sets of exercises and the frequency of exercise

    Time frame: Over 1 week

Secondary outcomes

  1. Usability

    A survey using the mhealth usability questionaire, with 18 questions, each question with scores of 1 to 7, 7 being fully agree and 1 fully disagree.

    Time frame: over 1 week

Other outcomes

  1. Technical reliability

    To measure if the device was able to synchronise with the app

    Time frame: over 1 week

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — Data is protected under the SingHealth Data Protection Policy which is compliant to the Singapore Personal Data Protection Act 2012

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 14, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06970717
Responsible party
Sponsor
First posted
May 14, 2025
Start date
Jun 1, 2025 (estimated)
Primary completion
Feb 28, 2026 (estimated)
Completion
Aug 31, 2026 (estimated)
Last update
May 14, 2025

Study contacts

San San Tay, MBBS
Contact
tay.san.san@singhealth.com.sg
65 69366455

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion